| Year |
Citation |
Score |
| 2023 |
Welch DR. Metastasis suppressors: a paradigm shift in cancer biology. Cancer Metastasis Reviews. PMID 37535138 DOI: 10.1007/s10555-023-10130-1 |
0.339 |
|
| 2023 |
Wei L, Zhang Q, Zhong C, He L, Zhang Y, Armaly AM, Aubé J, Welch DR, Xu L, Wu X. Functional inhibition of the RNA-binding protein HuR sensitizes triple-negative breast cancer to chemotherapy. Molecular Oncology. PMID 37357618 DOI: 10.1002/1878-0261.13478 |
0.338 |
|
| 2023 |
Harihar S, Welch DR. KISS1 metastasis suppressor in tumor dormancy: a potential therapeutic target for metastatic cancers? Cancer Metastasis Reviews. 42: 183-196. PMID 36720764 DOI: 10.1007/s10555-023-10090-6 |
0.374 |
|
| 2023 |
Welch DR. Dormancy in cancer metastasis: keys to moving forward. Cancer Metastasis Reviews. 42: 5-7. PMID 36680642 DOI: 10.1007/s10555-023-10083-5 |
0.331 |
|
| 2022 |
Yellapu NK, Ly T, Sardiu ME, Pei D, Welch DR, Thompson JA, Koestler DC. Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer. Bmc Cancer. 22: 627. PMID 35672711 DOI: 10.1186/s12885-022-09690-2 |
0.37 |
|
| 2021 |
Zimmermann RC, Sardiu ME, Manton CA, Miah MS, Banks CAS, Adams MK, Koestler DC, Hurst DR, Edmonds MD, Washburn MP, Welch DR. Perturbation of BRMS1 interactome reveals pathways that impact metastasis. Plos One. 16: e0259128. PMID 34788285 DOI: 10.1371/journal.pone.0259128 |
0.77 |
|
| 2021 |
Nathanson SD, Detmar M, Padera TP, Yates LR, Welch DR, Beadnell TC, Scheid AD, Wrenn ED, Cheung K. Mechanisms of breast cancer metastasis. Clinical & Experimental Metastasis. PMID 33950409 DOI: 10.1007/s10585-021-10090-2 |
0.393 |
|
| 2020 |
Young ED, Manley SJ, Beadnell TC, Shearin AE, Sasaki K, Zimmerman R, Kauffman E, Vivian CJ, Parasuram A, Iwakuma T, Grandgenett PM, Hollingsworth MA, O'Neil M, Welch DR. Suppression of pancreatic cancer liver metastasis by secretion-deficient ITIH5. British Journal of Cancer. PMID 33024269 DOI: 10.1038/s41416-020-01093-z |
0.321 |
|
| 2020 |
Wu X, Gardashova G, Lan L, Han S, Zhong C, Marquez RT, Wei L, Wood S, Roy S, Gowthaman R, Karanicolas J, Gao FP, Dixon DA, Welch DR, Li L, et al. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis. Communications Biology. 3: 193. PMID 32332873 DOI: 10.1038/s42003-020-0933-1 |
0.431 |
|
| 2020 |
Zimmermann RC, Welch DR. BRMS1: a multifunctional signaling molecule in metastasis. Cancer Metastasis Reviews. PMID 32232621 DOI: 10.1007/S10555-020-09871-0 |
0.404 |
|
| 2020 |
Ly T, Harihar S, Welch DR. KISS1 in metastatic cancer research and treatment: potential and paradoxes. Cancer Metastasis Reviews. PMID 32152912 DOI: 10.1007/S10555-020-09868-9 |
0.382 |
|
| 2020 |
Harihar S, Ray S, Narayanan S, Santhoshkumar A, Ly T, Welch DR. Role of the tumor microenvironment in regulating the anti-metastatic effect of KISS1. Clinical & Experimental Metastasis. PMID 32088827 DOI: 10.1007/S10585-020-10030-6 |
0.492 |
|
| 2020 |
Wu X, Wei L, Gardashova G, Zhong C, Lan L, Zhang Q, Dixon DA, Welch DR, Aubé J, Xu L. Abstract P5-05-09: Chemo-sensitization of triple negative breast cancer by targeting RNA-binding protein HuR Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P5-05-09 |
0.374 |
|
| 2019 |
Brinker AE, Vivian CJ, Beadnell TC, Koestler DC, Teoh ST, Lunt SY, Welch DR. Mitochondrial haplotype of the host stromal microenvironment alters metastasis in a non-cell autonomous manner. Cancer Research. PMID 31848195 DOI: 10.1158/0008-5472.Can-19-2481 |
0.372 |
|
| 2019 |
Ulasov IV, Borovjagin AV, Timashev P, Cristofanili M, Welch DR. KISS1 in breast Cancer progression and autophagy. Cancer Metastasis Reviews. PMID 31705228 DOI: 10.1007/S10555-019-09814-4 |
0.54 |
|
| 2019 |
Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R, Ali Sayed AA, Choudhury S, Standing D, Subramaniam D, Padhye S, Gunewardena S, Thomas SM, Neil MO, Tawfik O, ... Welch DR, et al. The Histone Demethylase KDM3A, Increased in Human Pancreatic Tumors, Regulates Expression of DCLK1 in and Promotes Tumorigenesis in Mice. Gastroenterology. PMID 31442435 DOI: 10.1053/J.Gastro.2019.08.018 |
0.422 |
|
| 2019 |
Yang J, Price MA, Wanshura LEC, He J, Yi M, Welch DR, Li G, Conner S, Sachs J, Turley EA, McCarthy JB. Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain. Melanoma Research. PMID 31140988 DOI: 10.1097/Cmr.0000000000000574 |
0.339 |
|
| 2019 |
Welch DR, Hurst DR. Defining the Hallmarks of Metastasis. Cancer Research. PMID 31053634 DOI: 10.1158/0008-5472.Can-19-0458 |
0.474 |
|
| 2019 |
Scheid AD, Beadnell TC, Welch DR. The second genome: Effects of the mitochondrial genome on cancer progression. Advances in Cancer Research. 142: 63-105. PMID 30885364 DOI: 10.1016/Bs.Acr.2019.01.001 |
0.359 |
|
| 2019 |
Pantoja-Uceda D, Neira JL, Contreras LM, Manton CA, Welch DR, Rizzuti B. The isolated C-terminal nuclear localization sequence of the breast cancer metastasis suppressor 1 is disordered. Archives of Biochemistry and Biophysics. PMID 30707944 DOI: 10.1016/J.Abb.2019.01.035 |
0.316 |
|
| 2019 |
Wu X, Gardashova G, Lan L, Han S, Zhong C, Gowthaman R, Karanicolas J, Dixon DA, Welch DR, Li L, Ji M, Aubé J, Xu L. Abstract 1235: Targeting RNA-binding protein HuR to inhibit human breast cancer invasion and metastasis Cancer Research. 79: 1235-1235. DOI: 10.1158/1538-7445.Am2019-1235 |
0.527 |
|
| 2018 |
Beadnell TC, Scheid AD, Vivian CJ, Welch DR. Roles of the mitochondrial genetics in cancer metastasis: not to be ignored any longer. Cancer Metastasis Reviews. PMID 30542781 DOI: 10.1007/S10555-018-9772-7 |
0.449 |
|
| 2018 |
Young ED, Strom K, Tsue AF, Usset JL, MacPherson S, McGuire JT, Welch DR. Automated quantitative image analysis for ex vivo metastasis assays reveals differing lung composition requirements for metastasis suppression by KISS1. Clinical & Experimental Metastasis. PMID 29582202 DOI: 10.1007/S10585-018-9882-1 |
0.418 |
|
| 2018 |
Welch DR. Abstract SY37-03: Mitochondrial genetic contributions to metastatic efficiency Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Sy37-03 |
0.433 |
|
| 2017 |
Kasemeier-Kulesa JC, Romine MH, Morrison JA, Bailey CM, Welch DR, Kulesa PM. NGF reprograms metastatic melanoma to a bipotent glial-melanocyte neural crest-like precursor. Biology Open. PMID 29175861 DOI: 10.1242/Bio.030817 |
0.39 |
|
| 2017 |
Brinker AE, Vivian CJ, Koestler DC, Tsue TT, Jensen RA, Welch DR. Mitochondrial haplotype alters mammary cancer tumorigenicity and metastasis in an oncogenic driver- dependent manner. Cancer Research. PMID 29070615 DOI: 10.1158/0008-5472.Can-17-2194 |
0.366 |
|
| 2017 |
Kaverina N, Borovjagin AV, Kadagidze Z, Baryshnikov A, Baryshnikova M, Malin D, Ghosh D, Shah N, Welch DR, Gabikian P, Karseladze A, Cobbs C, Ulasov IV. Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy. Autophagy. 1-19. PMID 28981380 DOI: 10.1080/15548627.2017.1360466 |
0.509 |
|
| 2017 |
Vivian CJ, Brinker AE, Graw S, Koestler DC, Legendre C, Gooden GC, Salhia B, Welch DR. Mitochondrial genomic backgrounds affect nuclear DNA methylation and gene expression. Cancer Research. PMID 28663334 DOI: 10.1158/0008-5472.Can-17-1473 |
0.304 |
|
| 2017 |
Manley SJ, Liu W, Welch DR. The KISS1 metastasis suppressor appears to reverse the Warburg effect by shifting from glycolysis to mitochondrial beta-oxidation. Journal of Molecular Medicine (Berlin, Germany). PMID 28597070 DOI: 10.1007/S00109-017-1552-2 |
0.352 |
|
| 2017 |
Xiao L, Tian X, Harihar S, Li Q, Li L, Welch DR, Zhou A. Gd2O3-doped silica @ Au nanoparticles for in vitro imaging cancer biomarkers using surface-enhanced Raman scattering. Spectrochimica Acta. Part a, Molecular and Biomolecular Spectroscopy. 181: 218-225. PMID 28365452 DOI: 10.1016/J.Saa.2017.03.033 |
0.339 |
|
| 2017 |
Sasaki K, Kurahara H, Young ED, Natsugoe S, Ijichi A, Iwakuma T, Welch DR. Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer. Clinical & Experimental Metastasis. PMID 28289921 DOI: 10.1007/S10585-017-9840-3 |
0.506 |
|
| 2017 |
Burikhanov R, Hebbar N, Noothi SK, Shukla N, Sledziona J, Araujo N, Kudrimoti M, Wang QJ, Watt DS, Welch DR, Maranchie J, Harada A, Rangnekar VM. Chloroquine-Inducible Par-4 Secretion Is Essential for Tumor Cell Apoptosis and Inhibition of Metastasis. Cell Reports. 18: 508-519. PMID 28076793 DOI: 10.1016/J.Celrep.2016.12.051 |
0.433 |
|
| 2017 |
Manley S, al-Ani G, Welch D. Abstract 5811: HMP19, a pancreatic cancer metastasis suppressor, is secreted in extracellular vesicles and inhibits EGFR activity Cancer Research. 77: 5811-5811. DOI: 10.1158/1538-7445.Am2017-5811 |
0.383 |
|
| 2017 |
Hampton KR, Pounds KM, Trembath AP, Welch DR. Abstract 4841: Suppression of metastasis by KP54 and non-KP54 kisspeptins Cancer Research. 77: 4841-4841. DOI: 10.1158/1538-7445.Am2017-4841 |
0.349 |
|
| 2017 |
Wu X, Marquez R, Han S, Lan L, Dixon DA, Aubé J, Welch DR, Xu L. Abstract 1145: Overcoming chemoresistance and blocking metastasis in breast cancer by targeting HuR Cancer Research. 77: 1145-1145. DOI: 10.1158/1538-7445.Am2017-1145 |
0.467 |
|
| 2016 |
Welch DR, Manton CA, Hurst DR. Breast Cancer Metastasis Suppressor 1 (BRMS1): Robust Biological and Pathological Data, But Still Enigmatic Mechanism of Action. Advances in Cancer Research. 132: 111-37. PMID 27613131 DOI: 10.1016/Bs.Acr.2016.05.003 |
0.491 |
|
| 2016 |
Welch DR. Tumor Cell Invasion-Not All Barriers Are Created Equal. Cancer Research. 76: 1675-1676. PMID 27197240 DOI: 10.1158/0008-5472.Can-16-0550 |
0.469 |
|
| 2016 |
Young ED, Welch DR. Targeting the Untargetable? Nodal Expression in TNBC. Cell Cycle (Georgetown, Tex.). 0. PMID 27027858 DOI: 10.1080/15384101.2016.1166816 |
0.304 |
|
| 2016 |
Kurahara H, Bohl C, Natsugoe S, Nishizono Y, Harihar S, Sharma R, Iwakuma T, Welch DR. Suppression of pancreatic cancer growth and metastasis by HMP19 identified through genome-wide shRNA screen. International Journal of Cancer. PMID 27012470 DOI: 10.1002/Ijc.30110 |
0.451 |
|
| 2016 |
Roesley SN, Suryadinata R, Morrish E, Tan AR, Issa SM, Oakhill JS, Bernard O, Welch DR, Šarčević B. Cyclin-dependent kinase-mediated phosphorylation of breast cancer metastasis suppressor 1 (BRMS1) affects cell migration. Cell Cycle (Georgetown, Tex.). 15: 137-51. PMID 26771717 DOI: 10.1080/15384101.2015.1121328 |
0.471 |
|
| 2016 |
Welch DR. Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions. Cancer Research. 76: 4-6. PMID 26729788 DOI: 10.1158/0008-5472.Can-15-3024 |
0.392 |
|
| 2016 |
Wu X, Marquez RT, Han S, Li K, Lan L, Guo Y, Dixon DA, Aubé J, Welch DR, Xu L. Abstract 4832: Overcoming breast cancer chemoresistance and blocking metastasis by targeting RNA-binding protein HuR Cancer Research. 76: 4832-4832. DOI: 10.1158/1538-7445.Am2016-4832 |
0.512 |
|
| 2016 |
Vivian CJ, Brinker AE, Gooden GC, Legendre C, Turpin S, Koestler DC, Salhia B, Welch DR. Abstract 2784: Mitochondrial genomic backgrounds affect nuclear DNA methylation and gene expression Cancer Research. 76: 2784-2784. DOI: 10.1158/1538-7445.Am2016-2784 |
0.357 |
|
| 2016 |
Brinker AE, Vivian CJ, Welch DR. Abstract 1696: Mitochondrial haplotype alters metastasis in a non-cell autonomous manner Cancer Research. 76: 1696-1696. DOI: 10.1158/1538-7445.Am2016-1696 |
0.436 |
|
| 2016 |
Hampton KR, Pounds KM, Trembath AP, Welch DR. Abstract 1615: Metastasis suppression by KP54 and non-KP54 kisspeptins Cancer Research. 76: 1615-1615. DOI: 10.1158/1538-7445.Am2016-1615 |
0.335 |
|
| 2015 |
Li Q, Xiao L, Harihar S, Welch DR, Vargis E, Zhou A. In vitro biophysical, microspectroscopic and cytotoxic evaluation of metastatic and non-metastatic cancer cells in responses to anti-cancer drug. Analytical Methods : Advancing Methods and Applications. 7: 10162-10169. PMID 26744605 DOI: 10.1039/C5Ay01810B |
0.528 |
|
| 2015 |
Feeley KP, Bray AW, Westbrook DG, Johnson LW, Kesterson RA, Ballinger SW, Welch DR. Mitochondrial Genetics Regulate Breast Cancer Tumorigenicity and Metastatic Potential. Cancer Research. 75: 4429-36. PMID 26471915 DOI: 10.1158/0008-5472.Can-15-0074 |
0.426 |
|
| 2015 |
Rangarajan P, Subramaniam D, Paul S, Kwatra D, Palaniyandi K, Islam S, Harihar S, Ramalingam S, Gutheil W, Putty S, Pradhan R, Padhye S, Welch DR, Anant S, Dhar A. Crocetinic acid inhibits hedgehog signaling to inhibit pancreatic cancer stem cells. Oncotarget. 6: 27661-73. PMID 26317547 DOI: 10.18632/Oncotarget.4871 |
0.389 |
|
| 2015 |
Bi Q, Ranjan A, Fan R, Agarwal N, Welch DR, Weinman SA, Ding J, Iwakuma T. MTBP inhibits migration and metastasis of hepatocellular carcinoma. Clinical & Experimental Metastasis. 32: 301-11. PMID 25759210 DOI: 10.1007/S10585-015-9706-5 |
0.432 |
|
| 2015 |
Vivian CJ, Brinker AE, Gooden GC, Legendre C, Salhia B, Welch DR. Abstract 5128: Changes in mitochondrial background affect nuclear DNA methylation Cancer Research. 75: 5128-5128. DOI: 10.1158/1538-7445.Am2015-5128 |
0.343 |
|
| 2015 |
Sasaki K, Kurahara H, Natsugoe S, Iwakuma T, Welch DR. Abstract 3264: Genome-wide shRNA screen identifies ITIH5 gene as a metastasis suppressor of pancreatic ductal adenocarcinoma (PDAC) Cancer Research. 75: 3264-3264. DOI: 10.1158/1538-7445.Am2015-3264 |
0.483 |
|
| 2015 |
Brinker AE, Vivian CJ, Feeley KP, Ballinger SW, Welch DR. Abstract 3262: Mitochondrial haplotype effects on tumor formation and metastasis are both cell autonomous and non-cell autonomous Cancer Research. 75: 3262-3262. DOI: 10.1158/1538-7445.Am2015-3262 |
0.456 |
|
| 2015 |
Contreras LM, Sarcevic B, Pounds KM, Welch DR. Abstract 3258: Breast Metastasis Suppressor 1 (BRMS1) phosphorylation appears necessary for metastasis suppressor activity Cancer Research. 75: 3258-3258. DOI: 10.1158/1538-7445.Am2015-3258 |
0.442 |
|
| 2015 |
Hampton KR, Pounds KM, Tremblath AP, Welch DR. Abstract 3253: Metastasis suppression by non-KP54 kisspeptins Cancer Research. 75: 3253-3253. DOI: 10.1158/1538-7445.Am2015-3253 |
0.372 |
|
| 2015 |
Sainathan SK, Paul S, Palaniyandi K, Subramaniam D, Ramalingam S, Tawfik OW, Iwakuma T, Welch DR, Padhye SB, Anant S, Dhar A. Abstract 2338: Histone demethylase KDM3A: Epigenetic target for pancreatic ductal adenocarcinoma (PDAC) Cancer Research. 75: 2338-2338. DOI: 10.1158/1538-7445.Am2015-2338 |
0.473 |
|
| 2014 |
Xiao L, Harihar S, Welch DR, Zhou A. Imaging of epidermal growth factor receptor on single breast cancer cells using surface-enhanced Raman spectroscopy. Analytica Chimica Acta. 843: 73-82. PMID 25150698 DOI: 10.1016/J.Aca.2014.06.036 |
0.454 |
|
| 2014 |
Liu W, Vivian CJ, Brinker AE, Hampton KR, Lianidou E, Welch DR. Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 7: 117-31. PMID 24938990 DOI: 10.1007/S12307-014-0148-4 |
0.492 |
|
| 2014 |
Khanna C, Fan TM, Gorlick R, Helman LJ, Kleinerman ES, Adamson PC, Houghton PJ, Tap WD, Welch DR, Steeg PS, Merlino G, Sorensen PH, Meltzer P, Kirsch DG, Janeway KA, et al. Toward a drug development path that targets metastatic progression in osteosarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4200-9. PMID 24803583 DOI: 10.1158/1078-0432.Ccr-13-2574 |
0.374 |
|
| 2014 |
Balgkouranidou I, Chimonidou M, Milaki G, Tsarouxa EG, Kakolyris S, Welch DR, Georgoulias V, Lianidou ES. Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer. British Journal of Cancer. 110: 2054-62. PMID 24642624 DOI: 10.1038/Bjc.2014.104 |
0.474 |
|
| 2014 |
Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb W, Welch DR, Grizzle W, Yates C. Nuclear localization of Kaiso promotes the poorly differentiated phenotype and EMT in infiltrating ductal carcinomas. Clinical & Experimental Metastasis. 31: 497-510. PMID 24570268 DOI: 10.1007/S10585-014-9644-7 |
0.457 |
|
| 2014 |
Liu W, Beck BH, Vaidya KS, Nash KT, Feeley KP, Ballinger SW, Pounds KM, Denning WL, Diers AR, Landar A, Dhar A, Iwakuma T, Welch DR. Metastasis suppressor KISS1 seems to reverse the Warburg effect by enhancing mitochondrial biogenesis. Cancer Research. 74: 954-63. PMID 24351292 DOI: 10.1158/0008-5472.Can-13-1183 |
0.379 |
|
| 2014 |
Bohl CR, Harihar S, Denning WL, Sharma R, Welch DR. Metastasis suppressors in breast cancers: mechanistic insights and clinical potential. Journal of Molecular Medicine (Berlin, Germany). 92: 13-30. PMID 24311119 DOI: 10.1007/S00109-013-1109-Y |
0.538 |
|
| 2014 |
Khotskaya YB, Beck BH, Hurst DR, Han Z, Xia W, Hung MC, Welch DR. Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix. Molecular Carcinogenesis. 53: 1011-26. PMID 24000122 DOI: 10.1002/Mc.22068 |
0.523 |
|
| 2014 |
Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb WM, Welch DR, Grizzle WE, Yates C. Nuclear localization of Kaiso as a prognostic biomarker and promotion of EMT in infiltrating ductal breast carcinomas. Journal of Clinical Oncology. 32: e22061-e22061. DOI: 10.1200/Jco.2014.32.15_Suppl.E22061 |
0.443 |
|
| 2014 |
Welch DR, Liu W, Feeley KP, Ballinger SW. Abstract SY20-03: Nuclear-mitochondrial cross-talk: A key determinant of cancer metastasis Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Sy20-03 |
0.394 |
|
| 2014 |
Ulasov IV, Kaverina NV, Yoon J, Lee H, Sarvaiya P, Malin D, Cryns VL, Welch DR, Cobbs CK. Abstract LB-191: Astrocytes promote colonization of human brain with breast cancer cells via inhibition of KISS1 expression Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-191 |
0.517 |
|
| 2014 |
Feeley KP, Bray AW, Fetterman JL, Westbrook DG, Johnson LW, Kesterson RA, Welch DR, Ballinger SW. Abstract 4326: Mitochondrial genetics and cellular metabolism regulate tumorigenicity and metastatic potential Cancer Research. 74: 4326-4326. DOI: 10.1158/1538-7445.Am2014-4326 |
0.406 |
|
| 2014 |
Balkouranidou I, Chimonidou M, Milaki G, Tsaroucha E, Kakolyris S, Welch D, Georgoulias V, Lianidou E. Abstract 3826: Breast cancer metastasis suppressor-1 promoter methylation in cell free DNA provides prognostic information in non-small cell lung cancer Cancer Research. 74: 3826-3826. DOI: 10.1158/1538-7445.Am2014-3826 |
0.421 |
|
| 2014 |
Bohl CR, Kurahara H, Natsugoe S, Nishizono Y, Harihar S, Iwakuma T, Welch DR. Abstract 1990: Identification and biochemical characterization of HMP19, a tumor/metastasis suppressor in pancreatic cancer Cancer Research. 74: 1990-1990. DOI: 10.1158/1538-7445.Am2014-1990 |
0.513 |
|
| 2014 |
Harihar S, Hampton KR, Iwakuma T, Seidah NG, Welch DR. Abstract 135: Phosphorylation and furin-mediated processing are critical posttranslational modifications of the KISS1 metastasis suppressor Cancer Research. 74: 135-135. DOI: 10.1158/1538-7445.Am2014-135 |
0.354 |
|
| 2014 |
Leahey KE, Welch DR, Chen Y, Bussard KM, Mastro AM. Abstract 130: Deadly KISS, Kisspeptin10 interaction with osteoblasts and breast cancer metastastic cells Cancer Research. 74: 130-130. DOI: 10.1158/1538-7445.Am2014-130 |
0.501 |
|
| 2014 |
Liu W, Beck B, Vaidya KS, Nash KT, Ballinger SW, Welch DR. Abstract 126: The KISS1 metastasis suppressor appears to integrate glycolysis, mitochondrial biogenesis and metastasis via regulation of a PGC1α pathway Cancer Research. 74: 126-126. DOI: 10.1158/1538-7445.Am2014-126 |
0.411 |
|
| 2013 |
Moon HJ, Finney J, Xu L, Moore D, Welch DR, Mure M. MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro. The Journal of Biological Chemistry. 288: 30000-8. PMID 24014025 DOI: 10.1074/Jbc.C113.502310 |
0.5 |
|
| 2013 |
Diers AR, Vayalil PK, Oliva CR, Griguer CE, Darley-Usmar V, Hurst DR, Welch DR, Landar A. Mitochondrial bioenergetics of metastatic breast cancer cells in response to dynamic changes in oxygen tension: effects of HIF-1α. Plos One. 8: e68348. PMID 23840849 DOI: 10.1371/Journal.Pone.0068348 |
0.376 |
|
| 2013 |
Chimonidou M, Kallergi G, Georgoulias V, Welch DR, Lianidou ES. Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells. Molecular Cancer Research : McR. 11: 1248-57. PMID 23744981 DOI: 10.1158/1541-7786.Mcr-13-0096 |
0.479 |
|
| 2013 |
Welch DR, Hurst DR. Unraveling the 'TGF-β paradox' one metastamir at a time. Breast Cancer Research : Bcr. 15: 305. PMID 23448381 DOI: 10.1186/Bcr3383 |
0.378 |
|
| 2013 |
Hurst DR, Xie Y, Thomas JW, Liu J, Edmonds MD, Stewart MD, Welch DR. The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression. Plos One. 8: e55966. PMID 23390556 DOI: 10.1371/Journal.Pone.0055966 |
0.792 |
|
| 2013 |
Agarwal N, Adhikari AS, Iyer SV, Hekmatdoost K, Welch DR, Iwakuma T. MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4. Oncogene. 32: 462-70. PMID 22370640 DOI: 10.1038/Onc.2012.69 |
0.461 |
|
| 2013 |
Feeley KP, Bray AW, Fetterman JL, Westbrook DG, Johnson LW, Kesterson RA, Welch DR, Ballinger SW. Abstract A090: Mitochondrial genetics in the regulation of tumorigenicity and metastatic potential Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-A090 |
0.384 |
|
| 2013 |
Liu W, Beck BH, Vaidya KS, Nash KT, Diers AR, Feeley KP, Landar A, Ballinger SW, Welch DR. Abstract 3866: The KISS1 metastasis suppressor appears to reverse the Warburg effect by enhancing mitochondria biogenesis. Cancer Research. 73: 3866-3866. DOI: 10.1158/1538-7445.Am2013-3866 |
0.43 |
|
| 2013 |
Harihar S, Pounds KM, Iwakuma T, Seidah NG, Welch DR. Abstract 3860: Furin is required for processing KISS1 to kisspeptins. Cancer Research. 73: 3860-3860. DOI: 10.1158/1538-7445.Am2013-3860 |
0.367 |
|
| 2013 |
Vayalil PK, Diers AR, Olivia CR, Griguer CE, Darley-Usmar V, Hurst DR, Welch DR, Landar A. Abstract 1864: Mitochondrial bioenergetics of metastatic breast cancer cells in response to decreasing oxygen tension. Cancer Research. 73: 1864-1864. DOI: 10.1158/1538-7445.Am2013-1864 |
0.415 |
|
| 2012 |
Welch DR. Preface. Metastasis genes. Cancer Metastasis Reviews. 31: 417-8. PMID 22695772 DOI: 10.1007/S10555-012-9386-4 |
0.309 |
|
| 2012 |
Winter SF, Lukes L, Walker RC, Welch DR, Hunter KW. Allelic variation and differential expression of the mSIN3A histone deacetylase complex gene Arid4b promote mammary tumor growth and metastasis. Plos Genetics. 8: e1002735. PMID 22693453 DOI: 10.1371/Journal.Pgen.1002735 |
0.537 |
|
| 2012 |
Slipicevic A, Holm R, Emilsen E, Ree Rosnes AK, Welch DR, Mælandsmo GM, Flørenes VA. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. Bmc Cancer. 12: 73. PMID 22356677 DOI: 10.1186/1471-2407-12-73 |
0.466 |
|
| 2012 |
Cook LM, Cao X, Dowell AE, Debies MT, Edmonds MD, Beck BH, Kesterson RA, Desmond RA, Frost AR, Hurst DR, Welch DR. Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis. Clinical & Experimental Metastasis. 29: 315-25. PMID 22241150 DOI: 10.1007/S10585-012-9452-X |
0.83 |
|
| 2012 |
Wang H, Jones J, Turner T, He QP, Hardy S, Grizzle WE, Welch DR, Yates C. Clinical and biological significance of KISS1 expression in prostate cancer. The American Journal of Pathology. 180: 1170-8. PMID 22226740 DOI: 10.1016/J.Ajpath.2011.11.020 |
0.425 |
|
| 2012 |
Bodenstine TM, Vaidya KS, Ismail A, Beck BH, Diers AR, Edmonds MD, Kirsammer GT, Landar A, Welch DR. Subsets of ATP-sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression. Febs Letters. 586: 27-31. PMID 22119728 DOI: 10.1016/J.Febslet.2011.11.017 |
0.733 |
|
| 2012 |
Ulasov IV, Kaverina NV, Pytel P, Thaci B, Liu F, Hurst DR, Welch DR, Sattar HA, Olopade OI, Baryshnikov AY, Kadagidze ZG, Lesniak MS. Clinical significance of KISS1 protein expression for brain invasion and metastasis. Cancer. 118: 2096-105. PMID 21928364 DOI: 10.1002/Cncr.26525 |
0.49 |
|
| 2012 |
Chimonidou M, Kallergi G, Georgoulias V, Welch D, Lianidou E. Abstract LB-283: Prognostic significance ofBRMS1promoter methylation in operable breast cancer. Cancer Research. 72: 3425-3425. DOI: 10.1158/1538-7445.Am2013-Lb-283 |
0.487 |
|
| 2012 |
Cook LM, Cao X, Dowell AE, Frost AA, Desmond RA, Edmonds MD, Kesterson RA, Hurst DR, Welch DR. Abstract 3416: Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis Cancer Research. 72: 3416-3416. DOI: 10.1158/1538-7445.Am2012-3416 |
0.829 |
|
| 2011 |
Subramaniam D, Nicholes ND, Dhar A, Umar S, Awasthi V, Welch DR, Jensen RA, Anant S. 3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesis. Molecular Cancer Therapeutics. 10: 2146-56. PMID 21890747 DOI: 10.1158/1535-7163.Mct-11-0399 |
0.453 |
|
| 2011 |
Hurst DR, Welch DR. Unraveling the enigmatic complexities of BRMS1-mediated metastasis suppression. Febs Letters. 585: 3185-90. PMID 21827753 DOI: 10.1016/J.Febslet.2011.07.045 |
0.437 |
|
| 2011 |
Lee S, Terry D, Hurst DR, Welch DR, Sang QX. Protein Signatures in Human MDA-MB-231 Breast Cancer Cells Indicating a More Invasive Phenotype Following Knockdown of Human Endometase/Matrilysin-2 by siRNA. Journal of Cancer. 2: 165-76. PMID 21475635 DOI: 10.7150/Jca.2.165 |
0.482 |
|
| 2011 |
Kwon YJ, Hurst DR, Steg AD, Yuan K, Vaidya KS, Welch DR, Frost AR. Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ERα negative breast cancer cell lines. Clinical & Experimental Metastasis. 28: 437-49. PMID 21442356 DOI: 10.1007/S10585-011-9382-Z |
0.526 |
|
| 2011 |
Bodenstine TM, Beck BH, Cao X, Cook LM, Ismail A, Powers SJ, Powers JK, Mastro AM, Welch DR. Pre-osteoblastic MC3T3-E1 cells promote breast cancer growth in bone in a murine xenograft model. Chinese Journal of Cancer. 30: 189-96. PMID 21352696 DOI: 10.5732/Cjc.010.10582 |
0.764 |
|
| 2011 |
Hurst DR, Welch DR. Metastasis suppressor genes at the interface between the environment and tumor cell growth. International Review of Cell and Molecular Biology. 286: 107-80. PMID 21199781 DOI: 10.1016/B978-0-12-385859-7.00003-3 |
0.479 |
|
| 2011 |
Cook LM, Hurst DR, Welch DR. Metastasis suppressors and the tumor microenvironment. Seminars in Cancer Biology. 21: 113-22. PMID 21168504 DOI: 10.1016/J.Semcancer.2010.12.005 |
0.728 |
|
| 2011 |
Li J, Cheng Y, Tai D, Martinka M, Welch DR, Li G. Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis. Oncogene. 30: 896-906. PMID 20935672 DOI: 10.1038/Onc.2010.470 |
0.391 |
|
| 2011 |
Welch DR, Beck BH, Feeley KP, Diers AR, Vaidya KS, Nash KT, Bodenstine TM, Thomas JW, Landar A, Ballinger SW. Abstract 965: The KISS1 metastasis suppressor appears to reverse the ‘Warburg Effect’ Cancer Research. 71: 965-965. DOI: 10.1158/1538-7445.Am2011-965 |
0.455 |
|
| 2011 |
Ulasov IV, Kaverina N, Thaci B, Pytel P, Sattar H, Cao D, Hurst DR, Welch DR, Olopade OI, Kadagidze ZG, Lesniak MS. Abstract 1439: Clinical significance of KISS1 protein expression in breast cancer metastasis to brain Cancer Research. 71: 1439-1439. DOI: 10.1158/1538-7445.Am2011-1439 |
0.513 |
|
| 2011 |
Khotskaya YB, Beck BH, Hurst DR, Hung M, Welch DR. Abstract 1438: Breast cancer metastasis suppressor 1 (BRMS1) suppresses attachment and spreading of breast cancer cells on 2D and 3D extracellular matrix components by altering focal adhesion-associated signaling Cancer Research. 71: 1438-1438. DOI: 10.1158/1538-7445.Am2011-1438 |
0.514 |
|
| 2011 |
Stewart MD, Edmonds MD, Powers JK, Hurst DR, Welch DR. Abstract 1437: Coordinate regulation of miR-183-96-182 and miR10b by Breast Cancer Metastasis Suppressor 1 results in a decrease in migration and invasion of metastatic breast cancer cells Cancer Research. 71: 1437-1437. DOI: 10.1158/1538-7445.Am2011-1437 |
0.739 |
|
| 2010 |
Bodenstine TM, Vaidya KS, Ismail A, Beck BH, Cook LM, Diers AR, Landar A, Welch DR. Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. Cancer Research. 70: 10002-11. PMID 21098703 DOI: 10.1158/0008-5472.Can-10-2606 |
0.734 |
|
| 2010 |
McNally LR, Welch DR, Beck BH, Stafford LJ, Long JW, Sellers JC, Huang ZQ, Grizzle WE, Stockard CR, Nash KT, Buchsbaum DJ. KISS1 over-expression suppresses metastasis of pancreatic adenocarcinoma in a xenograft mouse model. Clinical & Experimental Metastasis. 27: 591-600. PMID 20844932 DOI: 10.1007/S10585-010-9349-5 |
0.465 |
|
| 2010 |
Diers AR, Dranka BP, Ricart KC, Oh JY, Johnson MS, Zhou F, Pallero MA, Bodenstine TM, Murphy-Ullrich JE, Welch DR, Landar A. Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapy. The Biochemical Journal. 430: 69-78. PMID 20536428 DOI: 10.1042/Bj20091193 |
0.405 |
|
| 2010 |
Beck BH, Welch DR. The KISS1 metastasis suppressor: a good night kiss for disseminated cancer cells. European Journal of Cancer (Oxford, England : 1990). 46: 1283-9. PMID 20303258 DOI: 10.1016/J.Ejca.2010.02.023 |
0.504 |
|
| 2010 |
Bodenstine TM, Beck BH, Welch DR. Abstract 484: Treatment strategy to reverse osteolytic breast cancer metastasis using osteoblasts in a murine xenograft model Cancer Research. 70: 484-484. DOI: 10.1158/1538-7445.Am10-484 |
0.452 |
|
| 2010 |
Bodenstine TM, Vaidya KS, Ismail A, Cook LM, Welch DR. Abstract 1057: BRMS1 restoration of gap junctional intercellular communication involves modulation of KATPchannels and downregulation of phosphoinositide 3-kinase (PI3K) Cancer Research. 70: 1057-1057. DOI: 10.1158/1538-7445.Am10-1057 |
0.765 |
|
| 2009 |
Steeg PS, Anderson RL, Bar-Eli M, Chambers AF, Eccles SA, Hunter K, Itoh K, Kang Y, Matrisian LM, Sleeman JP, Theodorescu D, Thompson EW, Welch DR. An open letter to the FDA and other regulatory agencies: Preclinical drug development must consider the impact on metastasis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4529. PMID 25278743 DOI: 10.1158/1078-0432.Ccr-09-1363 |
0.355 |
|
| 2009 |
Richert MM, Welch DR. Metastasis of hormone receptor positive breast cancer. Cancer Treatment and Research. 147: 1-22. PMID 21461826 DOI: 10.1007/978-0-387-09463-2_6 |
0.432 |
|
| 2009 |
Hurst DR, Edmonds MD, Welch DR. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Research. 69: 7495-8. PMID 19773429 DOI: 10.1158/0008-5472.Can-09-2111 |
0.757 |
|
| 2009 |
Byon CH, Hardy RW, Ren C, Ponnazhagan S, Welch DR, McDonald JM, Chen Y. Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 1221-8. PMID 19752858 DOI: 10.1038/Labinvest.2009.97 |
0.506 |
|
| 2009 |
Edmonds MD, Hurst DR, Welch DR. Linking metastasis suppression with metastamiR regulation. Cell Cycle (Georgetown, Tex.). 8: 2673-5. PMID 19690456 DOI: 10.4161/Cc.8.17.9303 |
0.797 |
|
| 2009 |
Frolova N, Edmonds MD, Bodenstine TM, Seitz R, Johnson MR, Feng R, Welch DR, Frost AR. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 30: 148-59. PMID 19609101 DOI: 10.1159/000228908 |
0.786 |
|
| 2009 |
Edmonds MD, Hurst DR, Vaidya KS, Stafford LJ, Chen D, Welch DR. Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. International Journal of Cancer. Journal International Du Cancer. 125: 1778-85. PMID 19585508 DOI: 10.1002/Ijc.24616 |
0.756 |
|
| 2009 |
Vaidya KS, Sanchez JJ, Kim EL, Welch DR. Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells. Cancer Letters. 281: 100-7. PMID 19307053 DOI: 10.1016/J.Canlet.2009.02.035 |
0.548 |
|
| 2009 |
Richert MM, Vaidya KS, Mills CN, Wong D, Korz W, Hurst DR, Welch DR. Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone. Oncology Reports. 21: 761-7. PMID 19212637 DOI: 10.3892/Or_00000282 |
0.51 |
|
| 2009 |
Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Research. 69: 1279-83. PMID 19190326 DOI: 10.1158/0008-5472.Can-08-3559 |
0.749 |
|
| 2009 |
Cicek M, Fukuyama R, Cicek MS, Sizemore S, Welch DR, Sizemore N, Casey G. BRMS1 contributes to the negative regulation of uPA gene expression through recruitment of HDAC1 to the NF-kappaB binding site of the uPA promoter. Clinical & Experimental Metastasis. 26: 229-37. PMID 19165610 DOI: 10.1007/S10585-009-9235-1 |
0.301 |
|
| 2009 |
Silveira AC, Hurst DR, Vaidya KS, Ayer DE, Welch DR. Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells. Cancer Letters. 276: 32-7. PMID 19070953 DOI: 10.1016/J.Canlet.2008.10.024 |
0.46 |
|
| 2009 |
Hurst DR, Xie Y, Edmonds MD, Welch DR. Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Clinical & Experimental Metastasis. 26: 89-96. PMID 18841483 DOI: 10.1007/S10585-008-9216-9 |
0.787 |
|
| 2008 |
Bodenstine TM, Welch DR. Metastasis suppressors and the tumor microenvironment. Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society. 1: 1-11. PMID 19308680 DOI: 10.1007/S12307-008-0001-8 |
0.466 |
|
| 2008 |
Welch DR, Cooper CR, Hurst DR, Lynch CC, Martin MD, Vaidya KS, VanSaun MN, Mastro AM. Metastasis Research Society-American Association For Cancer Research Joint Conference on Metastasis. Cancer Research. 68: 9578-82. PMID 19047132 DOI: 10.1158/0008-5472.Can-08-3360 |
0.37 |
|
| 2008 |
Gladson CL, Welch DR. New insights into the role of CXCR4 in prostate cancer metastasis. Cancer Biology & Therapy. 7: 1849-51. PMID 18981717 DOI: 10.4161/Cbt.7.11.7218 |
0.407 |
|
| 2008 |
Li Z, Zhou Z, Welch DR, Donahue HJ. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clinical & Experimental Metastasis. 25: 893-901. PMID 18839320 DOI: 10.1007/S10585-008-9208-9 |
0.52 |
|
| 2008 |
Vaidya KS, Harihar S, Phadke PA, Stafford LJ, Hurst DR, Hicks DG, Casey G, DeWald DB, Welch DR. Breast cancer metastasis suppressor-1 differentially modulates growth factor signaling. The Journal of Biological Chemistry. 283: 28354-60. PMID 18664570 DOI: 10.1074/Jbc.M710068200 |
0.443 |
|
| 2008 |
Metge BJ, Frost AR, King JA, Dyess DL, Welch DR, Samant RS, Shevde LA. Epigenetic silencing contributes to the loss of BRMS1 expression in breast cancer. Clinical & Experimental Metastasis. 25: 753-63. PMID 18566899 DOI: 10.1007/S10585-008-9187-X |
0.532 |
|
| 2008 |
Hedley BD, Welch DR, Allan AL, Al-Katib W, Dales DW, Postenka CO, Casey G, Macdonald IC, Chambers AF. Downregulation of osteopontin contributes to metastasis suppression by breast cancer metastasis suppressor 1. International Journal of Cancer. Journal International Du Cancer. 123: 526-34. PMID 18470911 DOI: 10.1002/Ijc.23542 |
0.555 |
|
| 2008 |
Stafford LJ, Vaidya KS, Welch DR. Metastasis suppressors genes in cancer. The International Journal of Biochemistry & Cell Biology. 40: 874-91. PMID 18280770 DOI: 10.1016/J.Biocel.2007.12.016 |
0.497 |
|
| 2008 |
Phadke PA, Vaidya KS, Nash KT, Hurst DR, Welch DR. BRMS1 suppresses breast cancer experimental metastasis to multiple organs by inhibiting several steps of the metastatic process. The American Journal of Pathology. 172: 809-17. PMID 18276787 DOI: 10.2353/Ajpath.2008.070772 |
0.543 |
|
| 2008 |
Hurst DR, Xie Y, Vaidya KS, Mehta A, Moore BP, Accavitti-Loper MA, Samant RS, Saxena R, Silveira AC, Welch DR. Alterations of BRMS1-ARID4A interaction modify gene expression but still suppress metastasis in human breast cancer cells. The Journal of Biological Chemistry. 283: 7438-44. PMID 18211900 DOI: 10.1074/Jbc.M709446200 |
0.47 |
|
| 2008 |
Kapoor P, Suva LJ, Welch DR, Donahue HJ. Osteoprotegrin and the bone homing and colonization potential of breast cancer cells. Journal of Cellular Biochemistry. 103: 30-41. PMID 17471510 DOI: 10.1002/Jcb.21382 |
0.483 |
|
| 2008 |
Richert M, Wong D, Korz W, Welch D. 164 POSTER Inhibition of CXCR-4 reduces breast cancer xenograft metastasis to multiple organs European Journal of Cancer Supplements. 6: 52-53. DOI: 10.1016/S1359-6349(08)72096-2 |
0.365 |
|
| 2007 |
Cowin P, Welch DR. Breast cancer progression: controversies and consensus in the molecular mechanisms of metastasis and EMT. Journal of Mammary Gland Biology and Neoplasia. 12: 99-102. PMID 18769505 DOI: 10.1007/S10911-007-9041-9 |
0.466 |
|
| 2007 |
Hurst DR, Welch DR. A MSC-ing link in metastasis? Nature Medicine. 13: 1289-91. PMID 17987025 DOI: 10.1038/Nm1107-1289 |
0.462 |
|
| 2007 |
Champine PJ, Michaelson J, Weimer BC, Welch DR, DeWald DB. Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppression. Clinical & Experimental Metastasis. 24: 551-65. PMID 17896182 DOI: 10.1007/S10585-007-9092-8 |
0.486 |
|
| 2007 |
Lugassy C, Kleinman HK, Vernon SE, Welch DR, Barnhill RL. C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell-less chick chorioallantoic membrane assay. The British Journal of Dermatology. 157: 780-2. PMID 17711523 DOI: 10.1111/J.1365-2133.2007.08120.X |
0.383 |
|
| 2007 |
Vaidya KS, Welch DR. Metastasis suppressors and their roles in breast carcinoma. Journal of Mammary Gland Biology and Neoplasia. 12: 175-90. PMID 17587154 DOI: 10.1007/S10911-007-9049-1 |
0.534 |
|
| 2007 |
Eccles SA, Welch DR. Metastasis: recent discoveries and novel treatment strategies. Lancet. 369: 1742-57. PMID 17512859 DOI: 10.1016/S0140-6736(07)60781-8 |
0.433 |
|
| 2007 |
Sadlonova A, Mukherjee S, Bowe DB, Gault SR, Dumas NA, Van Tine BA, Frolova N, Page GP, Welch DR, Novak L, Frost AR. Human breast fibroblasts inhibit growth of the MCF10AT xenograft model of proliferative breast disease. The American Journal of Pathology. 170: 1064-76. PMID 17322389 DOI: 10.2353/Ajpath.2007.060031 |
0.461 |
|
| 2007 |
Nash KT, Phadke PA, Navenot JM, Hurst DR, Accavitti-Loper MA, Sztul E, Vaidya KS, Frost AR, Kappes JC, Peiper SC, Welch DR. Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy. Journal of the National Cancer Institute. 99: 309-21. PMID 17312308 DOI: 10.1093/Jnci/Djk053 |
0.392 |
|
| 2007 |
Samant RS, Clark DW, Fillmore RA, Cicek M, Metge BJ, Chandramouli KH, Chambers AF, Casey G, Welch DR, Shevde LA. Breast cancer metastasis suppressor 1 (BRMS1) inhibits osteopontin transcription by abrogating NF-kappaB activation. Molecular Cancer. 6: 6. PMID 17227585 DOI: 10.1186/1476-4598-6-6 |
0.564 |
|
| 2006 |
Welch DR. Do we need to redefine a cancer metastasis and staging definitions? Breast Disease. 26: 3-12. PMID 17473362 DOI: 10.3233/Bd-2007-26102 |
0.443 |
|
| 2006 |
Hicks DG, Yoder BJ, Short S, Tarr S, Prescott N, Crowe JP, Dawson AE, Budd GT, Sizemore S, Cicek M, Choueiri TK, Tubbs RR, Gaile D, Nowak N, Accavitti-Loper MA, ... ... Welch DR, et al. Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6702-8. PMID 17121889 DOI: 10.1158/1078-0432.Ccr-06-0635 |
0.466 |
|
| 2006 |
Hurst DR, Mehta A, Moore BP, Phadke PA, Meehan WJ, Accavitti MA, Shevde LA, Hopper JE, Xie Y, Welch DR, Samant RS. Breast cancer metastasis suppressor 1 (BRMS1) is stabilized by the Hsp90 chaperone. Biochemical and Biophysical Research Communications. 348: 1429-35. PMID 16919237 DOI: 10.1016/J.Bbrc.2006.08.005 |
0.386 |
|
| 2006 |
Mukherjee S, Frolova N, Sadlonova A, Novak Z, Steg A, Page GP, Welch DR, Lobo-Ruppert SM, Ruppert JM, Johnson MR, Frost AR. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biology & Therapy. 5: 674-83. PMID 16855373 DOI: 10.4161/Cbt.5.6.2906 |
0.519 |
|
| 2006 |
Shevde LA, Samant RS, Paik JC, Metge BJ, Chambers AF, Casey G, Frost AR, Welch DR. Osteopontin knockdown suppresses tumorigenicity of human metastatic breast carcinoma, MDA-MB-435. Clinical & Experimental Metastasis. 23: 123-33. PMID 16830223 DOI: 10.1007/S10585-006-9013-2 |
0.551 |
|
| 2006 |
Rinker-Schaeffer CW, O'Keefe JP, Welch DR, Theodorescu D. Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3882-9. PMID 16818682 DOI: 10.1158/1078-0432.Ccr-06-1014 |
0.397 |
|
| 2006 |
Lugassy C, Vernon SE, Busam K, Engbring JA, Welch DR, Poulos EG, Kleinman HK, Barnhill RL. Angiotropism of human melanoma: studies involving in transit and other cutaneous metastases and the chicken chorioallantoic membrane: implications for extravascular melanoma invasion and metastasis. The American Journal of Dermatopathology. 28: 187-93. PMID 16778482 DOI: 10.1097/00000372-200606000-00001 |
0.429 |
|
| 2006 |
Phadke PA, Mercer RR, Harms JF, Jia Y, Frost AR, Jewell JL, Bussard KM, Nelson S, Moore C, Kappes JC, Gay CV, Mastro AM, Welch DR. Kinetics of metastatic breast cancer cell trafficking in bone. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1431-40. PMID 16533765 DOI: 10.1158/1078-0432.Ccr-05-1806 |
0.731 |
|
| 2006 |
Nash KT, Welch DR. The KISS1 metastasis suppressor: mechanistic insights and clinical utility. Frontiers in Bioscience : a Journal and Virtual Library. 11: 647-59. PMID 16146758 DOI: 10.2741/1824 |
0.369 |
|
| 2006 |
Samant RS, Debies MT, Hurst DR, Moore BP, Shevde LA, Welch DR. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Letters. 235: 260-5. PMID 15978719 DOI: 10.1016/J.Canlet.2005.04.032 |
0.511 |
|
| 2005 |
Richert MM, Phadke PA, Matters G, DiGirolamo DJ, Washington S, Demers LM, Bond JS, Manni A, Welch DR. Metastasis of hormone-independent breast cancer to lung and bone is decreased by alpha-difluoromethylornithine treatment. Breast Cancer Research : Bcr. 7: R819-27. PMID 16168128 DOI: 10.1186/Bcr1292 |
0.524 |
|
| 2005 |
Koblinski JE, Kaplan-Singer BR, VanOsdol SJ, Wu M, Engbring JA, Wang S, Goldsmith CM, Piper JT, Vostal JG, Harms JF, Welch DR, Kleinman HK. Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Research. 65: 7370-7. PMID 16103089 DOI: 10.1158/0008-5472.Can-05-0807 |
0.791 |
|
| 2005 |
Cicek M, Fukuyama R, Welch DR, Sizemore N, Casey G. Breast cancer metastasis suppressor 1 inhibits gene expression by targeting nuclear factor-kappaB activity. Cancer Research. 65: 3586-95. PMID 15867352 DOI: 10.1158/0008-5472.Can-04-3139 |
0.501 |
|
| 2005 |
DeWald DB, Torabinejad J, Samant RS, Johnston D, Erin N, Shope JC, Xie Y, Welch DR. Metastasis suppression by breast cancer metastasis suppressor 1 involves reduction of phosphoinositide signaling in MDA-MB-435 breast carcinoma cells. Cancer Research. 65: 713-7. PMID 15705865 |
0.389 |
|
| 2005 |
Sadlonova A, Novak Z, Johnson MR, Bowe DB, Gault SR, Page GP, Thottassery JV, Welch DR, Frost AR. Breast fibroblasts modulate epithelial cell proliferation in three-dimensional in vitro co-culture. Breast Cancer Research : Bcr. 7: R46-59. PMID 15642169 DOI: 10.1186/Bcr949 |
0.467 |
|
| 2004 |
Kapoor P, Saunders MM, Li Z, Zhou Z, Sheaffer N, Kunze EL, Samant RS, Welch DR, Donahue HJ. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. International Journal of Cancer. Journal International Du Cancer. 111: 693-7. PMID 15252837 DOI: 10.1002/Ijc.20318 |
0.483 |
|
| 2004 |
Cicek M, Samant RS, Kinter M, Welch DR, Casey G. Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells. Clinical & Experimental Metastasis. 21: 149-57. PMID 15168732 DOI: 10.1023/B:Clin.0000024729.19084.F0 |
0.481 |
|
| 2004 |
Harms JF, Welch DR, Samant RS, Shevde LA, Miele ME, Babu GR, Goldberg SF, Gilman VR, Sosnowski DM, Campo DA, Gay CV, Budgeon LR, Mercer R, Jewell J, Mastro AM, et al. A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. Clinical & Experimental Metastasis. 21: 119-28. PMID 15168729 DOI: 10.1023/B:Clin.0000024763.69809.64 |
0.735 |
|
| 2004 |
Lugassy C, Kleinman HK, Engbring JA, Welch DR, Harms JF, Rufner R, Ghanem G, Patierno SR, Barnhill RL. Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. The American Journal of Pathology. 164: 1191-8. PMID 15039208 DOI: 10.1016/S0002-9440(10)63207-5 |
0.738 |
|
| 2004 |
Welch DR. Microarrays bring new insights into understanding of breast cancer metastasis to bone. Breast Cancer Research : Bcr. 6: 61-4. PMID 14979907 DOI: 10.1186/Bcr736 |
0.532 |
|
| 2004 |
Mastro AM, Gay CV, Welch DR, Donahue HJ, Jewell J, Mercer R, DiGirolamo D, Chislock EM, Guttridge K. Breast cancer cells induce osteoblast apoptosis: a possible contributor to bone degradation. Journal of Cellular Biochemistry. 91: 265-76. PMID 14743387 DOI: 10.1002/Jcb.10746 |
0.492 |
|
| 2004 |
Meehan WJ, Samant RS, Hopper JE, Carrozza MJ, Shevde LA, Workman JL, Eckert KA, Verderame MF, Welch DR. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. The Journal of Biological Chemistry. 279: 1562-9. PMID 14581478 DOI: 10.1074/Jbc.M307969200 |
0.436 |
|
| 2003 |
Welch DR, Harms JF, Mastro AM, Gay CV, Donahue HJ. Breast cancer metastasis to bone: evolving models and research challenges. Journal of Musculoskeletal & Neuronal Interactions. 3: 30-8. PMID 15758363 |
0.728 |
|
| 2003 |
Shevde LA, Welch DR. Metastasis suppressor pathways--an evolving paradigm. Cancer Letters. 198: 1-20. PMID 12893425 DOI: 10.1016/S0304-3835(03)00304-5 |
0.447 |
|
| 2003 |
Harms JF, Welch DR. MDA-MB-435 human breast carcinoma metastasis to bone. Clinical & Experimental Metastasis. 20: 327-34. PMID 12856720 DOI: 10.1023/A:1024062911144 |
0.75 |
|
| 2003 |
Manni A, Washington S, Craig L, Cloud M, Griffith JW, Verderame MF, Texter LJ, Mauger D, Demers LM, Harms JF, Welch DR. Effects of alpha-difluoromethylornithine on local recurrence and pulmonary metastasis from MDA-MB-435 breast cancer xenografts in nude mice. Clinical & Experimental Metastasis. 20: 321-5. PMID 12856719 DOI: 10.1023/A:1024055522067 |
0.775 |
|
| 2003 |
Welch DR, Hunter KW. A new member of the growing family of metastasis suppressors identified in prostate cancer. Journal of the National Cancer Institute. 95: 839-41. PMID 12813161 DOI: 10.1093/Jnci/95.12.839 |
0.314 |
|
| 2003 |
Mastro AM, Gay CV, Welch DR. The skeleton as a unique environment for breast cancer cells. Clinical & Experimental Metastasis. 20: 275-84. PMID 12741685 DOI: 10.1023/A:1022995403081 |
0.447 |
|
| 2003 |
Meehan WJ, Welch DR. Breast cancer metastasis suppressor 1: update. Clinical & Experimental Metastasis. 20: 45-50. PMID 12650606 DOI: 10.1023/A:1022542519586 |
0.515 |
|
| 2003 |
Harms JF, Welch DR, Miele ME. KISS1 metastasis suppression and emergent pathways. Clinical & Experimental Metastasis. 20: 11-8. PMID 12650602 DOI: 10.1023/A:1022530100931 |
0.766 |
|
| 2002 |
Harms JF, Budgeon LR, Christensen ND, Welch DR. Maintaining GFP tissue fluorescence through bone decalcification and long-term storage. Biotechniques. 33: 1197-200. PMID 12503297 DOI: 10.2144/02336Bm02 |
0.654 |
|
| 2002 |
Brown LM, Welch DR, Rannels SR. B16F10 melanoma cell colonization of mouse lung is enhanced by partial pneumonectomy. Clinical & Experimental Metastasis. 19: 369-76. PMID 12198764 DOI: 10.1023/A:1016345627965 |
0.371 |
|
| 2002 |
Manni A, Washington S, Griffith JW, Verderame MF, Mauger D, Demers LM, Samant RS, Welch DR. Influence of polyamines on in vitro and in vivo features of aggressive and metastatic behavior by human breast cancer cells. Clinical & Experimental Metastasis. 19: 95-105. PMID 11964084 DOI: 10.1023/A:1014536909007 |
0.535 |
|
| 2002 |
Brown LM, Welch DR, Rannels DE, Rannels SR. Partial pneumonectomy enhances melanoma metastasis to mouse lungs. Chest. 121: 28S-29S. PMID 11893665 DOI: 10.1378/Chest.121.3_Suppl.28S-A |
0.329 |
|
| 2002 |
Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, Mauger DT, Welch DR. Suppression of human melanoma metastasis by the metastasis suppressor gene, BRMS1. Experimental Cell Research. 273: 229-39. PMID 11822878 DOI: 10.1006/Excr.2001.5452 |
0.515 |
|
| 2002 |
Samant RS, Debies MT, Shevde LA, Verderame MF, Welch DR. Identification and characterization of the murine ortholog (brms1) of breast-cancer metastasis suppressor 1 (BRMS1). International Journal of Cancer. Journal International Du Cancer. 97: 15-20. PMID 11774238 DOI: 10.1002/Ijc.1569 |
0.41 |
|
| 2001 |
Debies MT, Welch DR. Genetic basis of human breast cancer metastasis. Journal of Mammary Gland Biology and Neoplasia. 6: 441-51. PMID 12013533 DOI: 10.1023/A:1014739131690 |
0.511 |
|
| 2001 |
Strasberg Rieber M, Welch DR, Rieber M. Suppression of C8161 melanoma metastatic ability by chromosome 6 induces differentiation-associated tyrosinase and decreases proliferation on adhesion-restrictive substrates mediated by overexpression of p21WAF1 and down-regulation of bcl-2 and cyclin D3. Biochemical and Biophysical Research Communications. 281: 159-65. PMID 11178974 DOI: 10.1006/Bbrc.2001.4330 |
0.411 |
|
| 2000 |
Samant RS, Seraj MJ, Saunders MM, Sakamaki TS, Shevde LA, Harms JF, Leonard TO, Goldberg SF, Budgeon L, Meehan WJ, Winter CR, Christensen ND, Verderame MF, Donahue HJ, Welch DR. Analysis of mechanisms underlying BRMS1 suppression of metastasis. Clinical & Experimental Metastasis. 18: 683-93. PMID 11827072 DOI: 10.1023/A:1013124725690 |
0.776 |
|
| 2000 |
Seraj MJ, Harding MA, Gildea JJ, Welch DR, Theodorescu D. The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines. Clinical & Experimental Metastasis. 18: 519-25. PMID 11592309 DOI: 10.1023/A:1011819621859 |
0.497 |
|
| 2000 |
Pethiyagoda CL, Welch DR, Fleming TP. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clinical & Experimental Metastasis. 18: 391-400. PMID 11467771 DOI: 10.1023/A:1010930918055 |
0.435 |
|
| 2000 |
Welch DR, Steeg PS, Rinker-Schaeffer CW. Molecular biology of breast cancer metastasis. Genetic regulation of human breast carcinoma metastasis. Breast Cancer Research : Bcr. 2: 408-16. PMID 11250734 DOI: 10.1186/Bcr87 |
0.523 |
|
| 2000 |
Yoshida BA, Sokoloff MM, Welch DR, Rinker-Schaeffer CW. Metastasis-suppressor genes: a review and perspective on an emerging field. Journal of the National Cancer Institute. 92: 1717-30. PMID 11058615 DOI: 10.1093/Jnci/92.21.1717 |
0.438 |
|
| 2000 |
Rinker-Schaeffer CW, Welch DR, Sokoloff M. Defining the biologic role of genes that regulate prostate cancer metastasis. Current Opinion in Urology. 10: 397-401. PMID 11005442 DOI: 10.1097/00042307-200009000-00006 |
0.442 |
|
| 2000 |
Miele ME, Jewett MD, Goldberg SF, Hyatt DL, Morelli C, Gualandi F, Rimessi P, Hicks DJ, Weissman BE, Barbanti-Brodano G, Welch DR. A human melanoma metastasis-suppressor locus maps to 6q16.3-q23 International Journal of Cancer. 86: 524-528. PMID 10797266 DOI: 10.1002/(Sici)1097-0215(20000515)86:4<524::Aid-Ijc13>3.0.Co;2-W |
0.311 |
|
| 1999 |
Goldberg SF, Harms JF, Quon K, Welch DR. Metastasis-suppressed C8161 melanoma cells arrest in lung but fail to proliferate. Clinical & Experimental Metastasis. 17: 601-7. PMID 10845559 DOI: 10.1023/A:1006718800891 |
0.748 |
|
| 1999 |
Kiley SC, Clark KJ, Duddy SK, Welch DR, Jaken S. Increased protein kinase C delta in mammary tumor cells: relationship to transformtion and metastatic progression. Oncogene. 18: 6748-57. PMID 10597283 DOI: 10.1038/Sj.Onc.1203101 |
0.434 |
|
| 1999 |
Welch DR, Rinker-Schaeffer CW. What defines a useful marker of metastasis in human cancer? Journal of the National Cancer Institute. 91: 1351-3. PMID 10451432 DOI: 10.1093/Jnci/91.16.1351 |
0.419 |
|
| 1998 |
Robertson GP, Furnari FB, Miele ME, Glendening MJ, Welch DR, Fountain JW, Lugo TG, Huang HJ, Cavenee WK. In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma. Proceedings of the National Academy of Sciences of the United States of America. 95: 9418-23. PMID 9689095 DOI: 10.1073/Pnas.95.16.9418 |
0.355 |
|
| 1998 |
Dennis JU, Dean NM, Bennett CF, Griffith JW, Lang CM, Welch DR. Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-α Cancer Letters. 128: 65-70. PMID 9652794 DOI: 10.1016/S0304-3835(98)00052-4 |
0.41 |
|
| 1998 |
Phillips KK, White AE, Hicks DJ, Welch DR, Barrett JC, Wei LL, Weissman BE. Correlation between reduction of metastasis in the MDA-MB-435 model system and increased expression of the Kai-1 protein. Molecular Carcinogenesis. 21: 111-20. PMID 9496911 DOI: 10.1002/(Sici)1098-2744(199802)21:2<111::Aid-Mc5>3.0.Co;2-Q |
0.478 |
|
| 1998 |
Welch DR, Goldberg SF. Molecular mechanisms controlling human melanoma progression and metastasis. Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology. 65: 311-30. PMID 9491851 DOI: 10.1159/000164143 |
0.333 |
|
| 1998 |
Welch DR, Wei LL. Genetic and epigenetic regulation of human breast cancer progression and metastasis Endocrine-Related Cancer. 5: 155-197. DOI: 10.1677/Erc.0.0050155 |
0.464 |
|
| 1997 |
Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL. KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Letters. 119: 149-55. PMID 9570365 DOI: 10.1016/S0304-3835(97)00273-5 |
0.522 |
|
| 1997 |
Lee JH, Welch DR. Identification of highly expressed genes in metastasis-suppressed chromosome 6/human malignant melanoma hybrid cells using subtractive hybridization and differential display. International Journal of Cancer. 71: 1035-44. PMID 9185708 DOI: 10.1002/(Sici)1097-0215(19970611)71:6<1035::Aid-Ijc20>3.0.Co;2-B |
0.394 |
|
| 1997 |
Welch DR. Technical considerations for studying cancer metastasis in vivo. Clinical & Experimental Metastasis. 15: 272-306. PMID 9174129 DOI: 10.1023/A:1018477516367 |
0.448 |
|
| 1997 |
Miele ME, De La Rosa A, Lee JH, Hicks DJ, Dennis JU, Steeg PS, Welch DR. Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23). Clinical & Experimental Metastasis. 15: 259-65. PMID 9174127 DOI: 10.1023/A:1018473415458 |
0.423 |
|
| 1996 |
Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, Welch DR. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene Journal of the National Cancer Institute. 88: 1731-1737. PMID 8944003 DOI: 10.1093/Jnci/88.23.1731 |
0.429 |
|
| 1996 |
Miele ME, Robertson G, Lee JH, Coleman A, McGary CT, Fisher PB, Lugo TG, Welch DR. Metastasis suppressed, but tumorigenicity and local invasiveness unaffected, in the human melanoma cell line MelJuSo after introduction of human chromosomes 1 or 6. Molecular Carcinogenesis. 15: 284-99. PMID 8634087 DOI: 10.1002/(Sici)1098-2744(199604)15:4<284::Aid-Mc6>3.0.Co;2-G |
0.316 |
|
| 1995 |
You J, Miele ME, Dong C, Welch DR. Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion. Biochemical and Biophysical Research Communications. 208: 476-84. PMID 7695596 DOI: 10.1006/Bbrc.1995.1363 |
0.405 |
|
| 1994 |
Miele ME, Bennett CF, Miller BE, Welch DR. Enhanced metastatic ability of TNF-α-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides Experimental Cell Research. 214: 231-241. PMID 7915992 DOI: 10.1006/Excr.1994.1253 |
0.394 |
|
| 1993 |
Welch DR, Harper DE, Yohem KH. U-77,863: a novel cinnanamide isolated from Streptomyces griseoluteus that inhibits cancer invasion and metastasis. Clinical & Experimental Metastasis. 11: 201-12. PMID 8444012 DOI: 10.1007/Bf00114978 |
0.421 |
|
| 1992 |
Seftor RE, Seftor EA, Grimes WJ, Liotta LA, Stetler-Stevenson WG, Welch DR, Hendrix MJ. Human melanoma cell invasion is inhibited in vitro by swainsonine and deoxymannojirimycin with a concomitant decrease in collagenase IV expression. Melanoma Research. 1: 43-54. PMID 1668368 DOI: 10.1097/00008390-199104000-00006 |
0.348 |
|
| 1991 |
Welch DR, Bisi JE, Miller BE, Conaway D, Seftor EA, Yohem KH, Gilmore LB, Seftor RE, Nakajima M, Hendrix MJ. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. International Journal of Cancer. 47: 227-37. PMID 1671030 DOI: 10.1002/Ijc.2910470211 |
0.418 |
|
| 1991 |
Yohem KH, Clothier JL, Montague SL, Geary RJ, Winters AL, Hendrix MJ, Welch DR. Inhibition of tumor cell invasion by verapamil Pigment Cell Research / Sponsored by the European Society For Pigment Cell Research and the International Pigment Cell Society. 4: 225-233. PMID 1668559 DOI: 10.1111/J.1600-0749.1991.Tb00445.X |
0.44 |
|
| 1990 |
Welch DR, McClure SA, Aeed PA, Bahner MJ, Adams LD. Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas. Clinical & Experimental Metastasis. 8: 533-51. PMID 2225568 DOI: 10.1007/Bf00135876 |
0.429 |
|
| 1990 |
Welch DR, Fabra A, Nakajima M. Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proceedings of the National Academy of Sciences of the United States of America. 87: 7678-82. PMID 2217201 DOI: 10.1073/Pnas.87.19.7678 |
0.312 |
|
| 1989 |
Aeed PA, Welch DR. Sensitivity of locally recurrent rat mammary tumour cell lines to syngeneic polymorphonuclear cell, macrophage and natural killer cell cytolysis. British Journal of Cancer. 58: 746-52. PMID 3224080 DOI: 10.1038/Bjc.1988.302 |
0.34 |
|
| 1989 |
Welch DR, Lobl TJ, Seftor EA, Wack PJ, Aeed PA, Yohem KH, Seftor REB, Hendrix MJC. Use of the Membrane Invasion Culture System (MICS) as a screen for anti-invasive agents. International Journal of Cancer. 43: 449-457. PMID 2925275 DOI: 10.1002/Ijc.2910430318 |
0.354 |
|
| 1989 |
Estrada J, Freeman DL, Aeed PA, Welch DR. Experimental model for locally recurring mammary tumors. Development, morphology, karyotype, growth kinetics, and experimental metastatic potential. Cancer. 63: 1353-62. PMID 2920363 DOI: 10.1002/1097-0142(19890401)63:7<1353::Aid-Cncr2820630721>3.0.Co;2-F |
0.373 |
|
| 1989 |
Welch DR, Schissel DJ, Howrey RP, Aeed PA. Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proceedings of the National Academy of Sciences of the United States of America. 86: 5859-63. PMID 2762301 DOI: 10.1073/Pnas.86.15.5859 |
0.449 |
|
| 1989 |
Scieszka J, Aeed P, Welch D, Cho M. Neutrophil-mediated transfer of polar substances from liposomes to mammary tumor cells in vitro International Journal of Pharmaceutics. 53: 167-173. DOI: 10.1016/0378-5173(89)90240-8 |
0.371 |
|
| 1988 |
Aeed PA, Nakajima M, Welch DR. The role of polymorphonuclear leukocytes (PMN) on the growth and metastatic potential of 13762NF mammary adenocarcinoma cells. International Journal of Cancer. 42: 748-59. PMID 2846449 DOI: 10.1002/Ijc.2910420521 |
0.429 |
|
| 1987 |
Tomasovic SP, Welch DR. Heat stress proteins and experimental cancer metastasis. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 2: 253-66. PMID 3794421 DOI: 10.3109/02656738609016484 |
0.344 |
|
| 1987 |
Tomasovic SP, Armour EP, North SM, Welch DR. Rat mammary adenocarcinoma heat-stress proteins in vivo. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 3: 467-73. PMID 3681047 DOI: 10.3109/02656738709140417 |
0.314 |
|
| 1986 |
Welch DR, Nicolson GL. Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro. Clinical & Experimental Metastasis. 1: 317-25. PMID 6242707 DOI: 10.1007/Bf00121194 |
0.557 |
|
| 1985 |
Welch DR, Krizman DB, Nicolson GL. Multiple phenotypic divergence of mammary adenocarcinoma cell clones. I. In vitro and in vivo properties. Clinical & Experimental Metastasis. 2: 333-55. PMID 6543709 DOI: 10.1007/Bf00135172 |
0.575 |
|
| 1985 |
Pearce V, Pathak S, Mellard D, Welch DR, Nicolson GL. Chromosome and DNA analyses of rat 13762NF mammary adenocarcinoma cell lines and clones of different metastatic potentials. Clinical & Experimental Metastasis. 2: 271-86. PMID 6543705 DOI: 10.1007/Bf00135167 |
0.542 |
|
| 1985 |
Welch DR, Tomasovic SP. Implications of tumor progression on clinical oncology. Clinical & Experimental Metastasis. 3: 151-88. PMID 3902300 DOI: 10.1007/Bf01786761 |
0.313 |
|
| 1984 |
Welch DR, Evans DP, Tomasovic SP, Milas L, Nicolson GL. Multiple phenotypic divergence of mammary adenocarcinoma cell clones. - II. Sensitivity to radiation, hyperthermia and FUdR Clinical &Amp; Experimental Metastasis. 2: 357-371. PMID 6242285 DOI: 10.1007/Bf00135173 |
0.469 |
|
| 1982 |
Neri A, Welch D, Kawaguchi T, Nicolson GL. Development and Biologic Properties of Malignant Cell Sublines and Clones of a Spontaneously Metastasizing Rat Mammary Adenocarcinoma Journal of the National Cancer Institute. 68: 507-517. DOI: 10.1093/Jnci/68.3.507 |
0.593 |
|
| Show low-probability matches. |